Amanote Research
Register
Sign In
Clinical Benefit of Sunitinib in Gastrointestinal Stromal Tumors With Different Exon 11 Mutation Genotypes
Future Oncology
- United Kingdom
doi 10.2217/fon-2017-0252
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Date
October 1, 2017
Authors
Zhi Dong
Jing Gao
Jifang Gong
Jie Li
Yanyan Li
Lin Shen
Jian Li
Publisher
Future Medicine Ltd
Related search
Unlucky Number 13? Differential Effects of KIT Exon 13 Mutation in Gastrointestinal Stromal Tumors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Canine and Human Gastrointestinal Stromal Tumors Display Similar Mutations in C-Kit Exon 11
BMC Cancer
Cancer Research
Oncology
Genetics
Genetic Polymorphisms as Predictive Biomarker of Survival in Patients With Gastrointestinal Stromal Tumors Treated With Sunitinib
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Gastrointestinal Stromal Tumors
Discussion of Clinical Cases
Gastrointestinal Stromal Tumors
Gastrointestinal Stromal Tumors
Deutsche Medizinische Wochenschrift
Medicine
Analysis of C-Kit Exon 9, Exon 11 and BRAFV600E Mutations Using Sangers Sequencing in Gastrointestinal Stromal Tumours
Cureus
Gastrointestinal Stromal Tumors in Equids
Veterinary Pathology
Veterinary
Clinical Relevance of the Location of Gastric Gastrointestinal Stromal Tumors
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
